Invitrogen™ Human DRAK2 Synthetic Peptide

Ref.: BL-RE-176800Manufacturer ref.: PEP-0052 50 μg
€149.00 excl. VAT

DRAK2 Synthetic Peptide, PEP-0052, from Invitrogen.

Gene ID (Enter)
9262
Species
Human
Purification method
Purified
Accession number
O94768
Common name
Human DRAK2
Brand
Invitrogen

DRAK2 Synthetic Peptide, PEP-0052, from Invitrogen.

DRAK2 Synthetic Peptide, PEP-0052, from Invitrogen.

STK17B (also known as DRAK2) is a member of the serine/threonine kinase family and is related to death-associated protein kinase that triggers apoptosis. STK17B is selectively important for T-cell survival and inhibition of STK17B has therapeutic potential for autoimmune disease. T-cell survival depends on a balance of T-cell receiver and co-stimulatory signals and deficiency of STK17B can affect autoimmune disease sensitivity without generalized suppression of the immune system. Protein kinases play important roles in the signal transduction in response to a variety of external stimulus. Recently, several proteins kinases have been identified that may also be involved in apoptotic process. Overexpression of a serine/threonine kinase, ZIP kinase can cause the morphological changes typical of apoptosis in NIH 3T3 cells. Sanjo et al, have identified two new protein kinases DRAK1 and DRAK2 (Death Receptor Associated Kinase 1 and 2). Both DRAKs and ZIP kinase share significant homology at the amino acid level. The kinase domains of both DRAKs, ZIP kinase are homologous to DAP (Death-associated protein) kinase, which is involved in the apoptotic signaling induced by interferon-g. Overexpression of DRAKs in NIH 3T3 cells lead to apoptosis. These transformation experiments suggest that C-terminal domain of DRAKs are important for induction of apoptosis.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15256279
Specifications
Gene ID (Enter)9262
SpeciesHuman
Purification methodPurified
Accession numberO94768
Common nameHuman DRAK2
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)STK17B
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0052
Country of originUnited States
HS customs code3824 99 96 00
A question or a specific configuration?
Contact us for a quote.